gbb@nic.MR.NET (Geoff Brunkhorst) (12/28/89)
Send all responses to addresses listed below. DO NOT REPLY TO THIS
EMAIL ADDRESS!
Please re-distribute/post
------------------------------------------------------------------------------
************************************
FELLOWSHIP ANNOUNCEMENT
ENDOCRINOLOGY/MOLECULAR ENDOCRINOLOGY
AND METABOLISM
MAYO CLINIC, ROCHESTER MN
*************************************
The Endocrine Research Unit, Mayo Clinic, consists of a
diverse but integrated faculty associated with a
world-reknowned academic medical center that is active in
basic and applied endocrine research. The faculty are all
NIH-supported and maintain a strong commitment toward the
understanding and treatment of endocrine disease as well as
to understanding basic mechanisms of hormone action. The
prinicpal areas of investigation include diabetes, lipid and
intermediary metabolism, bone/calcium metabolism, and
thyroid. There are now several openings in an NIH-funded
training program to support qualified individuals to perform
basic laboratory studies for up to three years. The various
programs provide excellent training experiences in
laboratories equipped with "state-of-the-art" technology in
molecular, cellular and organ-level endocrinology. NIH
stipends are supplemented according to standard Mayo policy;
Mayo is an Equal Opportunity Employer. Qualified applicants
must have completed their Ph.D. or M.D. degrees and must
be US Citizens or Non-Citizen Nationals (Alien Registration
Receipt I-151 or I-531).
FACULTY/AREA OF INTEREST
________________________________________
Norman L. Eberhardt, Ph.D., Training Program Director,
Mechanism of thyroid hormone action; molecular endocrinology
of gene expression.
Robert A. Rizza, M.D., Regulation of postabsorptive and
postprandial carbohydrate metabolism in diabetic and
non-diabetic man.
B. Lawrence Riggs, M.D., Epidemiology, pathogenesis, and
treatment of osteoporosis; bone markers; bone cell
metabolism.
Lorraine A. Fitzpatrick, M.D., Regulation of parathyroid
hormone secretion, control of osteoclast growth,
intracellular signalling mechanisms and bone
histomorphometry.
Cheryl A. Conover, Ph.D., Mechanism of action of
insulin-like growth factors (IGFs), role of IGF-binding
proteins.
F. John Service, M.D., Ph.D. Glucose control in diabetes
mellitus; pathophysiology of gut hormones; diabetic
Page 2
neuropathy.
John M. Miles, M.D., Free fatty acid and ketone body
metabolism; fuel homeostasis.
Russell T. Turner, Ph.D., Animal models for osteoporosis
and metabolic bone disease; hormones and bone; vitamin D.
________________________________________
Individuals interested in applying to the program
should send a letter indicating the applicant's particular
area of interest, the name of a potential mentor from the
faculty list, the names of three references and curriculum
vitae. Letters of inquiry should be sent to:
Norman L. Eberhardt, Ph.D.
Endocrinology Training Program Director
Endocrine Research Unit, 4-407 Alfred
Mayo Clinic
Rochester MN, 55905
PHONE: (507)285-6554 FAX: (507)285-4828
INTERNET: eberhardt@mayo.edu